Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Novartis has agreed to acquire Endocyte, a West Lafayette, Indiana-based biopharmaceutical company developing targeted therapeutics for cancer treatment, for $24 per share, or a total equity value of approximately $2.1 billion, in cash. The...

Merck KGaA has opened a new EUR 63-million ($72-million) packaging center at its headquarters in Darmstadt, Germany. The new 15,000-square-meter facility will be dedicated to packaging and shipping the company’s current portfolio of medicines to...

Merck & Co. plans to build a second biomanufacturing manufacturing facility at its site in Carlow, Ireland that will focus on producing vaccines and biologics. It will also expand warehouse and laboratory services at the site. The facility...

Shire has opened its more-than-$1-billion plasma manufacturing plant near Covington, Georgia. The more than one-million-square-foot facility will add approximately 30% capacity to Shire’s internal plasma manufacturing network once fully...

As part of the US Food and Drug Administration’s (FDA) efforts to promote drug competition and patient access, the agency has issued two draft guidances to advance the development of complex generic drugs. Complex generics are drugs that, by nature...

In keeping with a previously announced decision to divest its prescription (Rx) drug business and focus on consumer healthcare, Perrigo has appointed Murray S. Kessler, formerly Chief Executive Officer (CEO) of the Lorillard Tobacco Company, as...

GlaxoSmithKline (GSK) is closing part of its cephalosporins antibiotics manufacturing plant in Ulverston, England and planning staff reductions of approximately 200 employees. This follows a strategic review from which GSK decided to keep its...